Integral Diagnostics Limited (IDX.AX)

AUD 2.9

(-2.68%)

Operating Income Summary of Integral Diagnostics Limited

Integral Diagnostics Limited's latest annual operating income in 2024 was 5.36 Million AUD , down -86.63% from previous year.
Integral Diagnostics Limited's latest quarterly operating income in 2024 FY was 41.91 Million AUD , up 4.43% from previous quarter.
Integral Diagnostics Limited reported an annual operating income of 40.13 Million AUD in 2023, up 4.39% from previous year.
Integral Diagnostics Limited reported an annual operating income of 38.44 Million AUD in 2022, down -19.69% from previous year.
Integral Diagnostics Limited reported a quarterly operating income of 22.74 Million AUD for 2024 Q4, up 12.08% from previous quarter.
Integral Diagnostics Limited reported a quarterly operating income of 41.91 Million AUD for 2024 FY, up 4.43% from previous quarter.

Annual Operating Income Chart of Integral Diagnostics Limited (2024 - 2013)

Historical Annual Operating Income of Integral Diagnostics Limited (2024 - 2013)

Year	Operating Income	Operating Income Growth
2024	5.36 Million AUD	-86.63%
2023	40.13 Million AUD	4.39%
2022	38.44 Million AUD	-19.69%
2021	47.87 Million AUD	24.65%
2020	38.4 Million AUD	1.4%
2019	37.87 Million AUD	33.07%
2018	28.46 Million AUD	20.15%
2017	23.68 Million AUD	-10.64%
2016	26.5 Million AUD	5.72%
2015	25.07 Million AUD	620.64%
2014	3.47 Million AUD	7.73%
2013	3.22 Million AUD	0.0%

Year	Operating Income	Operating Income Growth
2024 Q2	20.28 Million AUD	-10.48%
2024 Q4	22.74 Million AUD	12.08%
2024 FY	41.91 Million AUD	4.43%
2023 Q2	17.9 Million AUD	1.83%
2023 FY	40.13 Million AUD	4.39%
2023 Q4	22.66 Million AUD	26.59%
2022 Q2	21.04 Million AUD	-1.52%
2022 FY	38.44 Million AUD	-19.69%
2022 Q4	17.58 Million AUD	-16.45%
2021 Q2	32.81 Million AUD	33.46%
2021 Q4	21.36 Million AUD	-34.88%
2021 FY	47.87 Million AUD	24.65%
2020 FY	38.4 Million AUD	1.4%
2020 Q4	24.58 Million AUD	11.97%
2020 Q2	21.95 Million AUD	20.6%
2019 Q4	18.2 Million AUD	-6.48%
2019 FY	37.87 Million AUD	33.07%
2019 Q2	19.46 Million AUD	34.86%
2018 Q4	14.43 Million AUD	2.91%
2018 Q2	14.02 Million AUD	19.19%
2018 FY	28.46 Million AUD	20.15%
2017 Q4	11.76 Million AUD	-1.26%
2017 FY	23.68 Million AUD	-10.64%
2017 Q2	11.91 Million AUD	-14.35%
2016 Q4	13.91 Million AUD	10.51%
2016 Q2	12.59 Million AUD	-5.16%
2016 FY	26.5 Million AUD	5.72%
2015 Q4	13.27 Million AUD	12.56%
2015 FY	25.07 Million AUD	620.64%
2015 Q2	11.79 Million AUD	0.0%
2014 FY	3.47 Million AUD	7.73%
2013 FY	3.22 Million AUD	0.0%

Peer Operating Income Comparison of Integral Diagnostics Limited

Name	Operating Income	Operating Income Difference
Australian Clinical Labs Limited	56.9 Million AUD	90.568%
BCAL Diagnostics Limited	-5.44 Million AUD	198.528%
Genetic Signatures Limited	-22.33 Million AUD	124.032%
Genetic Technologies Limited	-6.53 Million AUD	182.1%
Healius Limited	39.7 Million AUD	86.481%
Imagion Biosystems Limited	-15.81 Million AUD	133.938%
INOVIQ Ltd	-9.51 Million AUD	156.432%
Microba Life Sciences Limited	-26.84 Million AUD	119.994%
Monash IVF Group Limited	-5.34 Million AUD	200.43%
Rhythm Biosciences Limited	-6.7 Million AUD	180.018%
Sonic Healthcare Limited	816.45 Million AUD	99.343%